Eventide Asset Management »

Evommune shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17M 962k 17.12

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors
Dr. Jeffrey R. Jay, M.D.

View all funds holding Evommune